ICD-10 Coding for Supratherapeutic INR(D68.32, R79.83, Z92.1)
Complete ICD-10-CM coding and documentation guide for Supratherapeutic INR. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Supratherapeutic INR
D68.3-D68.32Primary Range
Hemorrhagic disorders due to intrinsic circulating anticoagulants
Primary range for conditions related to anticoagulant-induced coagulopathy.
Abnormal findings of blood chemistry
Used for abnormal coagulation profiles without bleeding.
Personal history of long-term (current) use of anticoagulants
Used when INR monitoring is documented.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D68.32 | Hemorrhagic disorder due to intrinsic circulating anticoagulants | Use when there is bleeding associated with supratherapeutic INR due to anticoagulants. |
|
| R79.83 | Abnormal coagulation profile | Use when INR is elevated without bleeding. |
|
| Z92.1 | Personal history of long-term (current) use of anticoagulants | Use when there is a documented history of INR monitoring. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for supratherapeutic INR
Essential facts and insights about Supratherapeutic INR
Primary ICD-10-CM Codes for supratherapeutic international normalized ratio
Decision Criteria
clinical Criteria
- Presence of bleeding symptoms
Applicable To
- Warfarin-induced coagulopathy with bleeding
Excludes
- R79.83 (Abnormal coagulation profile without bleeding)
Clinical Validation Requirements
- Lab-confirmed supratherapeutic INR
- Provider documentation of coagulopathy
- Bleeding manifestation
Code-Specific Risks
- Incorrectly coding without bleeding symptoms
Coding Notes
- Ensure bleeding is documented to use D68.32.
R79.83 - Abnormal coagulation profile
Use when INR is elevated without bleeding.
Applicable To
- Supratherapeutic INR without bleeding
Excludes
- D68.32 (Coagulopathy with bleeding)
Clinical Validation Requirements
- Lab-confirmed supratherapeutic INR
- No bleeding symptoms
Coding Notes
Ensure no bleeding is documented to use R79.83.
Z92.1 - Personal history of long-term (current) use of anticoagulants
Use when there is a documented history of INR monitoring.
Applicable To
- History of anticoagulant use with documented INR monitoring
Excludes
- R79.83 (when used for current INR elevation)
Clinical Validation Requirements
- Documentation of INR monitoring
Coding Notes
Ensure INR monitoring is documented.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Supratherapeutic INR to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D68.32.
Impact
Clinical: May lead to inappropriate treatment adjustments., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.
Mitigation Strategy
Always document the cause of INR elevation.
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Violates coding guidelines for exclusivity., Data Quality: Leads to inaccurate patient records.
Mitigation Strategy
Use R79.83 alone unless INR monitoring is explicitly documented.
Impact
Using mutually exclusive codes together.
Mitigation Strategy
Educate coders on exclusivity rules and proper documentation.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Supratherapeutic INR, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Supratherapeutic INR
Use these documentation templates to ensure complete and accurate documentation for Supratherapeutic INR. These templates include all required elements for proper coding and billing.
INR elevation due to drug interaction
Specialty: CardiologyRequired Elements
- INR value with date/time
- Causal agent
- Therapeutic intent
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Supratherapeutic INR? Ask your questions below.